Roles of Splicing Factors in Hormone-Related Cancer Progression

Toshihiko Takeiwa1, Yuichi Mitobe1, Kazuhiro Ikeda1

  • 1Division of Gene Regulation and Signal Transduction, Research Center for Genomic Medicine, Saitama Medical University, Hidaka, Saitama 350-1241, Japan.

Insights

Messenger RNA (mRNA) splicing generates diverse protein isoforms, crucial in cancer development. Targeting splicing mechanisms offers a promising new cancer therapy strategy, particularly for hormone-related cancers.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • Alternative splicing of messenger RNA precursors (pre-mRNA) generates multiple mRNA isoforms from a single gene.
  • Aberrant splicing is implicated in various cancers, influencing proliferation, migration, and hormone response.
  • Splicing-targeting therapies represent a novel and promising strategy for cancer treatment.

Purpose of the Study:

  • To review the role of RNA-binding proteins in regulating splicing events.
  • To focus on splicing regulation in hormone-related cancers like breast and prostate cancer.
  • To highlight the potential of splicing-targeting therapies.

Main Methods:

  • Review of existing scientific literature on mRNA splicing and cancer.
  • Analysis of the roles of specific RNA-binding protein families (DBHS, SR proteins, hnRNPs).
  • Focus on splicing alterations in hormone-dependent cancers.

Main Results:

  • Cancer-specific splicing events are integral to cancer progression.
  • RNA-binding proteins, including DBHS, SR proteins, and hnRNPs, are key regulators of these splicing events.
  • Dysregulated splicing in hormone-related cancers impacts key biological processes.

Conclusions:

  • Splicing regulation by RNA-binding proteins is critical in hormone-related cancers.
  • Understanding these mechanisms can lead to the development of targeted cancer therapies.
  • Splicing-targeting strategies hold significant therapeutic potential for breast and prostate cancers.

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.1K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
24.5K
Alternative RNA Splicing02:18

Alternative RNA Splicing

4.6K
Chromatin Structure Regulates pre-mRNA Processing02:41

Chromatin Structure Regulates pre-mRNA Processing

In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
8.0K
Pre-mRNA Processing: RNA Splicing01:36

Pre-mRNA Processing: RNA Splicing

6.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K